Metanx® P.L.U.S. Program (Progress Through Learning, Understanding & Support)

Status unconfirmed

Conditions studied: Diabetic Peripheral Neuropathy

In brief

This study will be an observational study in which patients who have been prescribed Metanx® are invited to participate in surveys regarding their experiences with Metanx®. The purpose of this study is to increase the understanding of the role of Metanx® in managing diabetic neuropathy, provide patients with personalized education and support, and contribute to the overall understanding of the needs and concerns of patients being treated for diabetic neuropathy.

Key facts

Study ID

NCT01368549

Run by

Pamlab, L.L.C.

People needed

800

Starts

2011-01-01

Expected to finish

2012-01-01

Last updated by the study team

2012-01-11

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• New Metanx® Start
• Diagnosis of Diabetic Peripheral Neuropathy who have been prescribed Metanx® to help metabolic management of endothelial dysfunction.

You may not qualify if…

• Patients who do not meet ADA criteria for DPN diagnosis.
• If participant indicates that he or she did not get a prescription for Metanx®, he/she will not be able to complete the survey(s).
• For follow-up surveys, if the participant indicates that he/she has not been taking Metanx®, he/she will not be able to complete the survey(s).

Where it is running

• Endocrinology Associates — Montgomery, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.